PMV Pharmaceuticals Inc (PMVP)
1.69
-0.12
(-6.37%)
USD |
NASDAQ |
Apr 24, 16:00
1.695
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Total Liabilities (Quarterly): 26.46M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.46M |
| September 30, 2023 | 23.42M |
| June 30, 2023 | 24.41M |
| March 31, 2023 | 23.79M |
| December 31, 2022 | 24.28M |
| September 30, 2022 | 23.79M |
| June 30, 2022 | 23.59M |
| March 31, 2022 | 23.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 23.01M |
| September 30, 2021 | 19.23M |
| June 30, 2021 | 18.06M |
| March 31, 2021 | 6.098M |
| December 31, 2020 | 6.41M |
| September 30, 2020 | 5.476M |
| June 30, 2020 | 5.147M |
| December 31, 2019 | 173.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.147M
Minimum
Jun 2020
173.51M
Maximum
Dec 2019
28.12M
Average
23.29M
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis Inc | 678.44M |
| Geron Corp | 146.13M |
| Verastem Inc | 92.34M |
| Karyopharm Therapeutics Inc | 376.64M |
| Kura Oncology Inc | 51.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.15M |
| Shareholders Equity (Quarterly) | 225.69M |